Putnam Investments LLC Buys New Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Putnam Investments LLC bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 314,000 shares of the pharmacy operator’s stock, valued at approximately $10,858,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Piscataqua Savings Bank raised its position in shares of Walgreens Boots Alliance by 156.4% in the first quarter. Piscataqua Savings Bank now owns 736 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 449 shares during the period. Private Ocean LLC raised its position in shares of Walgreens Boots Alliance by 65.6% in the first quarter. Private Ocean LLC now owns 757 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 300 shares during the period. American National Bank raised its position in shares of Walgreens Boots Alliance by 201.1% in the first quarter. American National Bank now owns 807 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 539 shares during the period. Pittenger & Anderson Inc. acquired a new position in shares of Walgreens Boots Alliance in the first quarter worth about $28,000. Finally, Activest Wealth Management acquired a new position in shares of Walgreens Boots Alliance in the first quarter worth about $31,000. 57.92% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Down 0.3 %

Shares of NASDAQ WBA opened at $22.42 on Friday. The company has a 50-day moving average of $27.47 and a 200 day moving average of $30.95. Walgreens Boots Alliance, Inc. has a 12-month low of $21.39 and a 12-month high of $42.29. The company has a quick ratio of 0.32, a current ratio of 0.63 and a debt-to-equity ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Tuesday, June 27th. The pharmacy operator reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.07). Walgreens Boots Alliance had a negative net margin of 2.44% and a positive return on equity of 12.62%. The firm had revenue of $35.42 billion during the quarter, compared to analysts’ expectations of $34.32 billion. During the same period last year, the company earned $0.96 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 4 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Monday, August 21st were paid a $0.48 dividend. The ex-dividend date of this dividend was Friday, August 18th. This represents a $1.92 annualized dividend and a dividend yield of 8.56%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -50.00%.

Analysts Set New Price Targets

A number of research analysts have weighed in on WBA shares. Credit Suisse Group decreased their price objective on shares of Walgreens Boots Alliance from $33.00 to $30.00 and set a “neutral” rating for the company in a research report on Thursday, August 24th. Truist Financial restated a “hold” rating and set a $30.00 price target on shares of Walgreens Boots Alliance in a research report on Tuesday, September 5th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating and reduced their price target for the stock from $46.00 to $34.00 in a research report on Wednesday, June 28th. Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $37.00 to $27.00 and set an “underweight” rating for the company in a research report on Monday, July 3rd. Finally, StockNews.com started coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 17th. They set a “hold” rating for the company. One research analyst has rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $36.23.

Read Our Latest Analysis on Walgreens Boots Alliance

Insider Activity

In other news, EVP John Patrick Driscoll purchased 5,172 shares of the company’s stock in a transaction dated Friday, June 30th. The stock was acquired at an average price of $28.42 per share, with a total value of $146,988.24. Following the purchase, the executive vice president now directly owns 59,050 shares in the company, valued at approximately $1,678,201. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Read More

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.